Rare disease | Australian Biotech Company News

Home Tags Rare disease

Biotechnology

Update: Novartis’ Gene Therapy Zolgensma Gets Nod from EU

BioChannel - May 19, 2020

Biotechnology

Phase III Failure Sinks Drug for Rare Neurological Disorder

BioChannel - May 8, 2020

Biotechnology

Update: FDA Imposes No Penalties for Novartis Data Manipulation Scandal

BioChannel - April 2, 2020

Biotechnology

Ipsen Resumes Phase III Testing for Rare Disease Drug and Abandons...

BioChannel - March 31, 2020

Biotechnology

First-in-Class Drug For Inherited Metabolic Diseases Funded with €25M

BioChannel - February 10, 2020

Biotechnology

Rare Inflammatory Disease Drug Beats Immunosuppressants in Phase III

BioChannel - November 26, 2019

Biotechnology

€51M Nasdaq IPO Will Fund Centogene’s Rare Disease Diagnostics

BioChannel - November 7, 2019

Biotechnology

FDA Considers Imposing Penalties on Novartis over Data Manipulation

BioChannel - August 7, 2019

Biotechnology

This Biotech Treats a Neurological Autoimmune Disorder Using DNA

BioChannel - May 31, 2019

Biotechnology

Update: Novartis’ Neurological Gene Therapy Receives FDA Approval

BioChannel - May 24, 2019

12 Page 1 of 2

Stay connected

Recent posts

Life in the Time of Coronavirus

BioChannel - July 10, 2020

Study pinpoints brain cells that trigger sugar cravings and consumption

BioChannel - July 10, 2020

Life Sciences Fund Launches with €76M to Invest in Nordic Biotech

BioChannel - July 10, 2020

Random article

Life in the Time of Coronavirus

Study pinpoints brain cells that trigger sugar cravings and consumption

Life Sciences Fund Launches with €76M to Invest in Nordic Biotech

VarmX bags €32m in Series B round – European Biotechnology News